EcoDrugPlus

Matrix Metallopeptidase 9

Ensembl ID : ENSDORG00000007765
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSDORG00000003771
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSDORG00000001167
Gene Symbol: MC3R
4 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSDORG00000029473
Gene Symbol: MC4R
4 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSDORG00000005478
Gene Symbol: MTNR1A
4 Cross references
216 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSDORG00000026210
Gene Symbol: MTNR1B
3 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSDORG00000005785
Gene Symbol: MME
4 Cross references
236 Possible Orthologues:

Membrane Primary Amine Oxidase-Like

Ensembl ID : ENSDORG00000000961
Gene Symbol: LOC106002643
3 Cross references
327 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSDORG00000000776
Gene Symbol: METAP2
4 Cross references
230 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSDORG00000010357
Gene Symbol: MAPT
4 Cross references
226 Possible Orthologues:

Microtubule Associated Serine/threonine Kinase 3

Ensembl ID : ENSDORG00000004244
Gene Symbol: MAST3
2 Cross references
253 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSDORG00000026548
Gene Symbol: MAPK1
4 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).